510(k) K261633
K261633 is an FDA 510(k) premarket notification submitted by Affirm Medical Technologies II, LLC for the device "VisuBreath". The FDA issued a decision of Substantially Equivalent on July 14, 2026. The device falls under product code CCK (Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase), a Class II device regulated under 21 CFR 868.1400.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- July 14, 2026
- Date Received
- May 18, 2026
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase
- Device Class
- Class II
- Regulation Number
- 868.1400
- Review Panel
- AN
- Submission Type